Chemistry:XXB 750
From HandWiki
Short description: Experimental drug
XXB 750 is an experimental injected drug that targets natriuretic peptide (NPR1) and is developed to treat resistant hypertension.[1][2] It was also tried for heart failure with reduced ejection fraction.[3]
References
- ↑ Janakiraman, Arun; Cohen, Debbie L. (27 September 2023). "New Potential Treatments for Resistant Hypertension". Current Cardiology Reports. doi:10.1007/s11886-023-01966-8.
- ↑ "XXB 750 - AdisInsight". https://adisinsight.springer.com/drugs/800068209.
- ↑ "Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF)". https://ichgcp.net/clinical-trials-registry/NCT05328752.
Original source: https://en.wikipedia.org/wiki/XXB 750.
Read more |